ASAM Guidelines for Stimulant Misuse Treatment

Initial Assessment and Treatment Approach

The American Society of Addiction Medicine (ASAM) recommends that patients with stimulant misuse be referred to specialized addiction treatment services, as primary care management alone is typically insufficient for stimulant dependence 1
A comprehensive evaluation should document the presence of co-occurring psychiatric disorders that may influence treatment approach, according to the American Medical Association, as reported in JAMA 2
The evaluation should also include a history of previous treatment attempts and outcomes, as suggested by the American Academy of Family Physicians 1

The American Academy of Child and Adolescent Psychiatry recommends cognitive-behavioral therapy (CBT) as an effective treatment for stimulant use disorder, which helps identify triggers for stimulant misuse and develop coping strategies 3

The American Medical Association, as reported in JAMA, emphasizes the importance of screening and treatment for co-occurring mental health conditions, such as anxiety and depression, which often contribute to stimulant misuse 2
The American Academy of Child and Adolescent Psychiatry suggests that integrated treatment addressing both substance use and mental health yields better outcomes than treating either condition alone 3
For patients with ADHD who have misused prescribed stimulants, the American Academy of Child and Adolescent Psychiatry recommends considering alternative non-stimulant medications, such as atomoxetine, which may be appropriate for treating ADHD symptoms without abuse potential 4

The American Academy of Child and Adolescent Psychiatry recommends establishing a continuing care plan before discharge from the inpatient program, which should include ongoing monitoring, recovery support, and early re-intervention if needed 5
The American Academy of Child and Adolescent Psychiatry also suggests that community and peer support resources, such as mutual help meetings and recovery organizations, provide valuable ongoing support 3
Family involvement in treatment improves outcomes when appropriate, as reported by the American Academy of Child and Adolescent Psychiatry 6

The American Medical Association, as reported in JAMA, warns against failing to address the risk of polysubstance use, as stimulant misuse often co-occurs with other substance use disorders 2
The American Medical Association, as reported in JAMA, also warns against overlooking the need for harm reduction strategies if complete abstinence is not immediately achieved 2
Discharging patients without a robust continuing care plan significantly increases relapse risk, according to the American Academy of Child and Adolescent Psychiatry 5
Focusing solely on the stimulant misuse without addressing underlying psychiatric conditions or psychosocial factors is also a common pitfall, as reported by the American Medical Association, as reported in JAMA, and the American Academy of Child and Adolescent Psychiatry 2, 3